Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel

The expression of O-GlcNAc transferase (OGT) and its catalytic product, O-GlcNAcylation (O-GlcNAc), are elevated in many types of cancers, including prostate cancer (PC). Inhibition of OGT serves as a potential strategy for PC treatment alone or combinational therapy. PC is the second common cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Mingyue, Wang, Shuyan, Qi, Yannan, Long, Kaili, Li, Enjie, He, Lingfeng, Pan, Feiyan, Guo, Zhigang, Hu, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686342/
https://www.ncbi.nlm.nih.gov/pubmed/36439421
http://dx.doi.org/10.3389/fonc.2022.993243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686342/
https://www.ncbi.nlm.nih.gov/pubmed/36439421
http://dx.doi.org/10.3389/fonc.2022.993243

Ejemplares similares